13F reference period
n/a
CUSIP: 758338305
13F reference period
n/a
Institutions Reporting
Shares (Excl. Options)
Price
$1.00
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
758338305
13F reference period
n/a
13F holders
13D/G owners
3
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 758338305:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Era Regenerative Medicine Ltd | 58% | -2.8% | $53,043,803 | +$2,021,506 | 28,214,789 | +4% | Era Regenerative Medicine Ltd | 04 Jun 2025 |
| DENG Shufen | 60% | $51,022,296 | 27,139,519 | D&D Source of Life Holding Ltd. | 30 Dec 2024 | |||
| WHITEBOX ADVISORS LLC | 0.8% | $484,557 | 257,743 | WHITEBOX ADVISORS LLC | 31 Dec 2024 |
Quarter history
Holder count, reported shares/value, and median price by quarter.